Please note the webcast will not begin until 8:30 AM CT.

Join Senseonics for an in-person and virtual analyst event with company management to discuss the next-generation Eversense^® 365 Continuous Glucose Monitoring (CGM) system, approved by the U.S. Food and Drug Administration (FDA) for people with diabetes aged 18 years and older.

Along with comments from management, the event will feature Brian Hansen (Ascencia Diabetes Care), who will speak to the commercial launch of Eversense 365 and its use in clinical practice, and Gary Graf, MSN, APRN-C (Cotton-O’Neil Diabetes and Endocrinology Center), who will speak to experience with the Eversense platform and insertion procedure. Company management will also discuss the recently announced partnership with Sequel to integrate with the twiist automated insulin delivery pump and plans to advance its pipeline of implantable CGM technology. The event will be held in conjunction with the American Diabetes Association 85^th Scientific Sessions (ADA 2025), taking place June 20-23, 2025 in Chicago, Illinois.

A live question and answer session will follow the formal presentations.